Monday, May 27, 2019

Cidara Yeast Infection Gel Fails Phase 2 (CDTX) – Investopedia

February 22, 2017 by  
Filed under Yeast Infection News


Cidara Yeast Infection Gel Fails Phase 2 (CDTX)
Cidara Therapeutics Inc. (CDTX) said its yeastinfection gel CD101 failed a Phase 2 trial for treating acute vulvovaginal candidiasis (VVC). The San Diego-based company had been evaluating the gel and ointment topical formulations in women suffering
Cidara's CD101 flunks mid-stage study in acute yeast infections; shares plummet 35% premarketSeeking Alpha
Cidara Antifungal Flunks in Phase 2 Clinical Trial, Sinking SharesXconomy

all 100 news articles »

Brought to you by Google News. Read the rest of the article here


Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

Before you post, please prove you are sentient.

What is 8 multiplied by 4?